Emergency room infusion of intravenous streptokinase in acute myocardial infarction: Feasibility, safety, and hemodynamic consequences
- 12 May 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 117 (5) , 1018-1022
- https://doi.org/10.1016/0002-8703(89)90856-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.Heart, 1988
- Recent changes in management of acute myocardial infarction: Implications for emergency care physiciansJournal of the American College of Cardiology, 1988
- Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: Improved timing, thrombolytic efficacy and ventricular functionJournal of the American College of Cardiology, 1987
- Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?Circulation, 1986
- Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardiumThe American Journal of Cardiology, 1986
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Practical guidelines for treatment with beta-blockers and nitrates in patients with acute myocardial infarctionEuropean Heart Journal, 1983
- Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1979